Abt Associates has taken bold action to help prevent opioid misuse and overdose. Our work has helped address the supply of and demand for illegal drugs and the misuse of legal substances for federal, state and local agencies, as well as other key stakeholders. We’ve pioneered research strategies to estimate the worldwide supply of illegal drugs, led research on drug-trafficking organizations, and evaluated the effectiveness of substance use disorder treatment programs. Abt has also developed and tested tools to improve opioid prescribing. Our team of multidisciplinary experts brings critical insight and approaches to help access the hard-to-reach and at-risk substance-using populations.
Together, our research, policy analysis, program implementation, technical support and communication activities inform real-world practices to ensure the greatest positive impacts on our communities.
Abt developed a strategic plan for the Massachusetts’ Health Policy Commission and has broad understanding of the opioid prevention and treatment continuum.
Abt developed guidance for clinicians on best practices for opioid prescribing and has evaluated formulary management approaches.
Abt has extensive experience conducting evaluations across the continuum of substance abuse prevention and treatment. Abt is a leader in developing and evaluating resources for clinicians to improve opioid prescribing guidelines and prescription monitoring programs, among others.
Abt has supported and evaluated the implementation of CDC guideline recommendations in health systems.
Abt has extensive experience conducting research and data analysis. Abt also recently developed measures to monitor health systems’ prescribing and patient care practices.
Abt has developed a set of measures for monitoring the implementation of the CDC guideline recommendations in clinical practice. We also developed and operated the Arrestee Drug Abuse Monitoring program.
Abt led several projects for the CDC and SAMHSA developing evidence-based resources for clinicians, health systems, and treatment programs.
Abt supported the development of the first-ever Surgeon General’s Report on Alcohol, Drugs, and Health (SGR-ADH). This report discusses the growing relationship between prescription drug misuse and heroin use, and provides evidence-based strategies for addressing the growing opioid epidemic.
Abt has evaluated a SAMHSA-HIV program by looking at opioid misuse as a precursor, along with HEP-C.
Abt assisted with the development of APPS for first responders to locate treatment and to aid individuals in reentering the community after incarceration to find care for opioid use disorders.
Abt is researching workforce programs that aim to improve employment outcomes for low-income adults who struggle with addiction and substance use disorders, including opioids.
Abt is a global leader in research, monitoring and evaluation. Harnessing rigorous methodologies—ranging from randomized experiments and rapid cycle evaluations to performance monitoring and in-depth qualitative analysis—we enable decision makers to answer hard questions and solve challenging problems. We know how to test what works, discover why it works, and provide timely evidence-based recommendations.
Opioid Use, Misuse and Overdose
Select from our growing list of insights below.
Abt Associates is an engine for social impact, harnessing the power of data and grounded insight to bring people from vulnerability to security worldwide. We think boldly to deliver solutions that cross disciplines, methods, and geographies. Abt provides impact through research, evaluation, and program implementation in the fields of health, social and environmental policy, and international development.